Drugs / Inlive®
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04993365 Comparator | Nov 2021 → Jul 2022 | COVID-19 | Sinovac Research and Development Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inlive | “inactivated enterovirus type 71 vaccine (Inlive®)” PMID 39313857 ↗ Sep 2024 |
| Modality | Vaccine | “inactivated enterovirus type 71 vaccine (Inlive®)” PMID 39313857 ↗ Sep 2024 |